Skip to content

News Category: Health & Medical

Sai Life Sciences inks strategic agreement to set up Schrödinger’s first dedicated offshore Research Laboratories in India

By asianet

Sai Life Sciences, one of India’s fastest growing global Contract Research, Development & Manufacturing Organisations [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the Sai Schrödinger Research Laboratories (SSRL) in Hyderabad, … Continued

CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vision of “Going for Zero” — Zero Heart Attacks and Zero Strokes

By asianet

– “Viso,” New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 – OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient-monitoring service to realize its “Going for Zero” vision to eliminate heart attack and stroke at the world’s largest Consumer Electronic Show (CES 2023). The Company is … Continued

B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital in Tokyo

By asianet

– Memorandum of Understanding Signed with Edogawa Hospital – B dot Medical Inc. has signed a memorandum of understanding with Edogawa Hospital in Japan for the installation of the company’s first practical ultra-compact proton therapy system, which means the first proton therapy facility to be established in Tokyo. Logo: https://kyodonewsprwire.jp/img/202212211482-O2-n1O2n8B4 Image1: Edogawa Hospital in Tokyo, … Continued

DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference

By asianet

DiscGenics, Inc. ( https://c212.net/c/link/?t=0&l=en&o=3748183-1&h=827169717&u=https%3A%2F%2Fwww.discgenics.com%2F&a=DiscGenics ), a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA on January … Continued

Alphyn Biologics Reports Positive Results from First Cohort of Phase 2a Trial of Mild-to-Moderate Atopic Dermatitis Treatment

By asianet

Study met all primary endpoints Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3747842-1&h=3266796279&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3709054-1%26h%3D2795132862%26u%3Dhttps%253A%252F%252Falphynbiologics.com%252F%26a%3DAlphyn%2BBiologics&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today positive results from the first cohort of its Phase 2a clinical trial of AB-101a, a topical therapeutic for mild-to-moderate atopic dermatitis (AD). The trial met all of its primary endpoints, highlighting AB-101a’s potential to be … Continued

Non-invasive in vitro diagnostic (IVD) test enables early detection of colorectal cancer

By asianet

The DNA Methylation Detection Kit for Human SDC2, ADHFE1 and PPP2R5C Genes (Real-Time PCR), the colorectal cancer early detection product under BGI’s wholly-owned subsidiary BGI Biotechnology (Wuhan) Co., Ltd., has recently obtained the medical device market access certification from Agencia Nacional de Vigilancia Sanitaria (hereinafter referred to as ANVISA), with a registration number 80117581027. Stool … Continued

PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

By asianet

PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first patient treated in its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical trial of PMB-CT01 (BAFFR-CAR T Cells) has reached Complete Response at 1-month post treatment. The trial is taking place … Continued

Huaiyin in Jinan, Shandong, Intent on Transforming into China’s Top Health and Wellness City

By asianet

According to information released on December 13 by the People’s Government of Huaiyin District, Huaiyin will expend all necessary effort on building a new medical science city comprising an international smart medical city, a green health demonstration zone and a health and wellness tourism demonstration site. This will be achieved by fully capitalizing on the … Continued

Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination

By asianet

Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced a clinical trial collaboration and supply agreement. This agreement covers the execution of a Phase 2 clinical trial to evaluate the novel combination of Carrick’s samuraciclib (CT7001), an oral and … Continued

Health and Hydrogen launches one of the first medical-grade Molecular Hydrogen Inhalation Machine HAH-301

By asianet

Molecular Hydrogen Inhalation therapy is now extensively used for its many health benefits, such as reducing inflammation, improving cellular function, and protecting against oxidative stress. Health And Hydrogen [ https://healthandhydrogen.com/ ] recently launched a revolutionary, easy-to-use medical-grade molecular hydrogen inhalation HAH- 301 [ https://healthandhydrogen.com/product/ ] device to provide patients with these benefits. This device can … Continued